SHAREHOLDERS’ EQUITY | NOTE 6 – SHAREHOLDERS’ EQUITY Restricted Stock Grants The following table summarizes restricted common stock activity: SUMMARY OF RESTRICTED COMMON STOCK Number of Fair Value Weighted Non-vested, September 30, 2021 8,750,000 $ 325,000 $ 0.03 Granted - - - Vested (2,500,000 ) (87,500 ) 0.04 Forfeited - - - Non-vested, March 31, 2022 6,250,000 $ 237,500 $ 0.04 During the three and six months ended March 31, 2022, the Company recorded $ 43,750 87,500 237,500 In addition to the above grants, during the year ended September 30, 2021, the Company’s Board of Directors approved the issuance of a combined total of 41,353,731 Stock Options On December 22, 2010, effective retroactively as of June 30, 2010, the Company’s Board of Directors approved the adoption of the “2010 Non-Qualified Stock Option Plan” (“2010 Option Plan”) by unanimous consent. The 2010 Option Plan was initiated to encourage and enable officers, directors, consultants, advisors and key employees of the Company to acquire and retain a proprietary interest in the Company by ownership of its common stock. A total of 7,500,000 7,500,000 30,000,000 The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award. Additionally, the Company’s policy is to issue new shares of common stock to satisfy stock option exercises. The Company applied fair value accounting for all share-based payments awards. The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model. The table below summarizes the Company’s stock option activities for the six months ended March 31, 2022: SCHEDULE OF STOCK OPTION ACTIVITY Number of Option Shares Exercise Price Range Per Share Weighted Average Balance, September 30, 2021 5,277,738 $ 0.03 0.26 $ 0.15 Granted - - - Cancelled - - - Exercised - - - Expired (850,000 ) 0.12 0.26 0.17 Balance, March 31, 2022 4,427,738 $ 0.03 0.26 $ 0.14 Vested and exercisable, March 31, 2022 4,427,738 $ 0.03 0.26 $ 0.14 Unvested, March 31, 2022 - $ - $ - The following table summarizes information concerning outstanding and exercisable options as of March 31, 2022: SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS BY EXERCISE PRICE RANGE Options Outstanding Options Exercisable Range of Exercise Prices Number Average Weighted Number Average Weighted $ 0.03 0.26 4,427,738 1.33 $ 0.14 4,427,738 1.33 $ 0.14 $ 0.03 0.26 4,427,738 1.33 $ 0.14 4,427,738 1.33 $ 0.14 During the six months ended March 31, 2022, no no As of March 31, 2022, there were 25,572,262 3,125 Stock Warrants The table below summarizes the Company’s warrants activities for the six months ended March 31, 2022: SCHEDULE OF WARRANT ACTIVITY Number of Exercise Weighted Average Balance, September 30, 2021 32,032,075 $ 0.07 0.40 $ 0.16 Granted - - - Cancelled - - - Exercised - - - Expired (3,775,278 ) 0.15 0.15 Balance, March 31, 2022 28,256,797 $ 0.07 0.40 $ 0.16 Vested and exercisable, March 31, 2022 28,256,797 $ 0.07 0.40 $ 0.16 The following table summarizes information concerning outstanding and exercisable warrants as of March 31, 2022: SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS BY EXERCISE PRICE RANGE Warrants Outstanding Warrants Exercisable Range of Exercise Prices Number Average Weighted Number Average Weighted $ 0.07 0.20 27,306,797 1.47 $ 0.16 27,306,797 1.47 $ 0.16 0.21 0.40 950,000 0.96 0.33 950,000 0.96 0.33 $ 0.07 0.40 28,256,797 1.45 $ 0.16 28,256,797 1.45 $ 0.16 There was no |